Company intelligence / Profile preview

acib

Graz, Styria, Austria
Ownership
Private
Employees
~200
Development stage
Other
01

Overview

acib is an Austrian non-profit industrial biotechnology research organization that operates at the interface of academia and industry. The center develops biocatalytic, microbial, bioprocess, biopharmaceutical, diagnostic, and bio-based manufacturing technologies for pharmaceutical, biotech, chemical, food, feed, agriculture, materials, and environmental applications. Rather than a single-asset therapeutics developer, acib functions as a collaborative R&D and innovation platform supporting translational research, contract research, and technology transfer with large pharma, biotech companies, startups, and academic institutions. Its work spans enzyme engineering, synthetic biology, cell engineering, downstream processing, diagnostics, and renewable-resource biorefineries, with a stated focus on enabling a bio-based circular economy and better health for all. The organization is publicly owned by Austrian universities and research institutions and is funded in part through the COMET competence center program.

Modalities
BiologicProteinRecombinant proteinVaccineGene therapyEnzyme replacement therapySmall moleculeMicrobial therapy
Industry
Academic Hospital/University/Research

Beyond the preview

Go deeper on acib.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on acib.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call